BRAF and melanoma: In this report, we present evidence that upregulation of CD47 expression is an important immunosuppressive mechanism triggered by BRAF/MEK inhibitors that prevents macrophage phagocytosis of melanoma cells, and may thus contribute to impairment of anti-melanoma T cell responses [23, 24].